Bioenvision
Bioenvision engages in the acquisition, development and marketing of compounds and technologies primarily for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Bioenvision Information
Bioenvision was acquired by
Genzyme.
The acquisition happend on 2007-05-29.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: New York
State: New York
Zip:
Country: United States
Financial Info
Stage:
series unknown
Raised Last:
$7M
Raised Total:$7M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Bioenvision a biopharmaceutical company, engages in the acquisition, development, and marketing of compounds and technologies primarily for the treatment of cancer. Its lead products include Evoltra (clofarabine) which has marketing approval in both the European Union and United States for the treatment of pediatric relapsed or refractory acute lymphoblastic leukemia and Modrenal (trilostane), which has marketing approval in the United Kingdom for the treatment of post-menopausal breast cancer following relapse to initial hormone therapy.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2007 | Venture Round | 2 | $7.4M |
Aisling Capital Perseus Aisling Capital Perseus |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
